An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma

An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma

Aim: The EMulate Therapeutics Voyager™ is a simple, wearable, home-use device that uses an alternating electromagnetic field to alter biologic signaling within cells. Objective: To assess the safety/feasibility of the Voyager in the treatment of recurrent glioblastoma (rGBM). Methods: In this study,...

Full description

Bibliographic Details
Main Authors: Garni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, Sajeel Chowdhary, Charles Cobbs, Julius Paul Duic, John Paul Flores, Ekokobe Fonkem, Edward McClay, Louis Burt Nabors, Michael Salacz, Lynn Taylor, Brian Vaillant, Jaya Gill, Santosh Kesari
Format: Article
Language:English
Published: Taylor & Francis Group 2023-09-01
Series:CNS Oncology
Subjects:
brain tumor
clinical trial
electromagnetic field
GBM
medical device
novel therapy
Online Access:https://www.futuremedicine.com/doi/10.2217/cns-2022-0016

Internet

https://www.futuremedicine.com/doi/10.2217/cns-2022-0016

Similar Items